Evidence for a stimulatory role of high doses of recombinant human follicle-stimulating hormone in the treatment of male-factor infertility

Andrologia

Volumn 46, Issue 9, 2014, Pages 1067-1072

  Paradisi, R ^a   Natali, F ^a   Fabbri, R ^a   Battaglia, C ^a   Seracchioli, R ^a   Venturoli, S ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Male factor infertility; Oligoasthenozoospermia; Pregnancy rate; Recombinant human follicle stimulating hormone treatment; Sperm concentration

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PLACEBO; PROLACTIN; RECOMBINANT FOLLITROPIN; TESTOSTERONE; RECOMBINANT PROTEIN;

ABSENCE OF SIDE EFFECTS; ARTICLE; CELL STRUCTURE; CELL VIABILITY; CHRONOTHERAPY; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; ESTRADIOL BLOOD LEVEL; EVIDENCE BASED PRACTICE; FOLLITROPIN BLOOD LEVEL; HORMONAL THERAPY; HUMAN; INFERTILITY THERAPY; LONG TERM CARE; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MALE INFERTILITY; MULTIPLE CYCLE TREATMENT; OLIGOSPERMIA; PARTHENOGENESIS; PREGNANCY RATE; PROLACTIN BLOOD LEVEL; SEMEN ANALYSIS; SINGLE DRUG DOSE; SPERM QUALITY; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION; ASTHENOZOOSPERMIA; BLOOD; FEMALE; INFERTILITY, MALE; PATHOLOGY; PREGNANCY;

ASTHENOZOOSPERMIA; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; INFERTILITY, MALE; LUTEINIZING HORMONE; MALE; OLIGOSPERMIA; PREGNANCY; PROLACTIN; RECOMBINANT PROTEINS; SPERM COUNT; TESTOSTERONE;

EID: 84907919986     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/and.12194     Document Type: Article

References (30)

1. Acosta AA, Oehninger S, Ertunc H, Philput C (1991) Possible role of pure human follicle- stimulating hormone in the treatment of severe male-factor infertility by assisted reproduction: preliminary report. Fertil Steril 55:1150-1156.
2. Acosta AA, Khalifa E, Oehninger S (1992) Pure human follicle-stimulating hormone has a role in the treatment of severe male infertility by assisted reproduction: Norfolk's total experience. Hum Reprod 7:1067-1072.
3. Arnaldi G, Balercia G, Barbatelli G, Mantero F (2000) Effects of long-term treatment with human pure follicle-stimulating hormone on semen parameters and sperm-cell ultrastructure in idiopathic oligoteratoasthenozoospermia. Andrologia 32:155-161.
4. Ashkenazi J, Bar-Hava I, Farhi J, Levy T, Feldberg D, Orvieto R, Ben-Rafael Z (1999) The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection. Fertil Steril 72:670-673.
5. Attia AM, Al-Inany HG, Farquhar C, Proctor M (2007) Gonadotropins for idiopathic male factor subfertility. Cochrane Database Syst Rev 25:CD005071.
6. Baccetti B, Piomboni P, Bruni E, Capitani S, Gambera L, Moretti E, Sterzik K, Strehler E (2004) Effect of follicle-stimulating hormone on sperm quality and pregnancy rate. Asian J Androl 6:133-137.
7. Bartoov B, Har-Evn D, Eltes F, Ledermann H, Lunenfeld E, Lunenfeld B (1994) Sperm quality of subfertile males before and after treatment with human follicle-stimulating hormone. Fertil Steril 61:727-734.
8. Ben-Rafael Z, Farhi J, Feldberg D, Bartoov B, Kovo M, Eltes F, Ashkenazi J (2000) Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilisation potential. Fertil Steril 73:24-30.
9. Caroppo E, Niederberger C, Vizziello GM, D'Amato G (2003) Recombinant human follicle-stimulating hormone as a pretreatment for idiopathic oligoasthenoteratozoospermic patients undergoing intracytoplasmic sperm injection. Fertil Steril 80:1398-1403.
10. Carreau S, Lambard S, Delalande C, Denis-Galeraud I, Bilinska B, Bourguiba S (2003) Aromatase expression and role of estrogens in male gonad: a review. Reprod Biol Endocrinol 1:35.
11. le Cotonnec JY, Porchet HC, Beltrami V, Khan A, Toon S, Rowland M (1994) Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). II. Single doses and steady state pharmacokinetics. FSH. Fertil Steril 61:679-686.
12. Dirnfeld M, Katz G, Calderon I, Abramovici H, Bider D (2000) Pure follicle-stimulating hormone as an adjuvant therapy for selected cases in male infertility during in-vitro fertilization is beneficial. Eur J Obstet Gynecol Reprod Biol 93:105-108.
13. Foresta C, Bettella A, Ferlin A, Garolla A, Rossato M (1998) Evidence for a stimulatory role of follicle stimulating hormone on the spermatogonial population in adult males. Fertil Steril 69:636-642.
14. Foresta C, Bettella A, Merico M, Garolla A, Ferlin A, Rossato M (2002) Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility. Fertil Steril 77:238-244.
15. Foresta C, Bettella A, Garolla A, Ambrosini G, Ferlin A (2005) Treatment of male idiopathic infertility with recombinat human follicle-stimulating hormone: a prospective, controlled, randomized clinical study. Fertil Steril 84:654-661.
16. Isidori AM, Pozza C, Gianfrilli D, Isidori A (2006) Medical treatment to improve sperm quality. Reprod Biomed Online 6:704-714.
17. Jockenhovel F, Fingscheidt U, Khan SA, Behre HM (1990) Immunoactivity of FSH in serum after intramuscular injection of highly purified urinary human FSH in normal men. Clin Endocrinol (Oxf) 33:573-584.
18. Kamischke A, Nieschlag E (1999) Analysis of medical treatment of male infertility. Hum Reprod 14 (Suppl. 1):1-23.
19. Kamischke A, Behre HM, Bergmann M, Simoni M, Schafer T, Nieschlag E (1998) Recombinant human stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. Hum Reprod 13:596-603.
20. Kumar R, Gautam G, Gupta NP (2006) Drug therapy for idiopathic male infertility: rationale versus evidence. J Urol 176:1307-1312.
21. Loumaye E, Campbell R, Salat-Baroux J (1995) Human follicle-stimulating hormone produced by recombinant DNA technology: a review for clinicians. Hum Reprod Update 1:188-199.
22. Mannaerts B, Fauser B, Lahlou N, Harlin J, Shoham Z, Bennink HC, Bouchard P (1996) Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism. Fertil Steril 65:406-410.
23. Matorras R, Perez C, Corcostegui B, Pijoan JI, Ramon O, Delgado P, Rodriguez-Escudero FJ (1997) Treatment of the male with follicle-stimulating hormone in intrauterine insemination with husband's spermatozoa: a randomized study. Hum Reprod 12:24-28.
24. Matsumoto AM, Karpas AE, Bremner WJ (1986) Chronic human chorionic gonadotropin administration in normal men: evidence that follicle stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man. J Clin Endocrinol Metab 62:1184-1192.
25. Paradisi R, Lodi S, Bolelli G, Venturoli S (1980) Radioimmunoassay of three oestrogens and three androgens in the same plasma sample after extraction and chromatographic separation. Eur J Endocrinol 94:229-234.
26. Paradisi R, Mancini R, Bellavia E, Beltrandi E, Pession AL, Venturoli S, Flamigni C (1997) T-helper 2 type citokine and solubile interleukin-2 receptor levels in seminal plasma of infertile men. Am J Reprod Immunol 38:94-99.
27. Paradisi R, Busacchi P, Seracchioli R, Porcu E, Venturoli S (2006) Effects of high doses of recombinant human follicle-stimulating hormone in the treatment of male factor infertility: results of a pilot study. Fertil Steril 86:728-731.
28. Plant TM, Marshall GR (2001) The functional significance of FSH in spermatogenesis and the control of its secretion in male primates. Endocr Rev 22:764-786.
29. Saal W, Baum RP, Happ J, Schmidt M, Cordes U (1991) Subcutaneous gonadotropin therapy in male patients with hypogonadotropic hygonadism. Fertil Steril 56:319-324.
30. World Health Organization (WHO) (1999) Laboratory manual for the examination of human semen and sperm-cervical mucus interaction. Cambridge University Press, Cambridge.